MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • Trius Therapeutics, Inc. (TSRX) Completes Patient Enrollment In Second Phase III Of Tedizolid 0 comments
    Dec 10, 2012 5:56 PM | about stocks: MRK

    Trius Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative antibiotics for life-threatening infections. The company's lead investigational drug is tedizolid phosphate (TR-701), a once daily, IV and orally-administered second generation oxazolidinone in Phase 3 clinical development for the treatment of serious infections, including MRSA.

    The company announced today that it has reached its enrollment objective of 658 patients in the last of its two Phase 3 clinical trials of tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections. The key Phase 3 trial examines the efficacy and safety of a six-day course of tedizolid administered once a day versus a 10-day course of linezolid (Zyvox) administered twice a day to patients.

    Last year, Trius completed its earlier study testing the oral drug dosing of tedizolid under the same trial design and endpoints as the current Phase 3 trial. The trial achieved all primary and secondary efficacy outcomes and showed significant safety and tolerability improvements versus linezolid.

    The company remains on schedule to report top-line results from the Phase 3 study in early 2013. For additional information about Trius Therapeutics and its tedizolid phosphate treatment for skin infections, please visit www.triusrx.com.

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: MRK
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.